Tender Details

Country: Finland
Summary: Request for Information: Equipment and Reagents for the Analysis of Biological Drug Assays
FIT Ref No: 115299202
Deadline: 11 Apr 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 125124-2025
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The aim of this request for information is to find out the availability of equipment and reagents for the analysis of biological drug assays. The procurement unit aims to obtain comprehensive information of equipment, reagents, supplies and/or instrumentation including maintenance service and technical support available. This information may be used in a possible future call for tenders. The equipment that fulfills the need should meet the following requirements: - Random access analyzer - Analyzer and reagents have a CE-IVD mark. If not, are these under the CE-IVDR process, and what is the estimated time for the CE-IVDR approval? - Quantitative analyses Mandatory analytes (to be analyzed with same analyzer): - Infliximab, concentration from serum (approximately 2500 samples per year) - Adalimumab, concentration from serum (approximately 1100 samples per year) - Vedolizumab, concentration from serum (approximately 500 samples per year) - Ustekinumab, concentration from serum (approximately 300 samples per year) Optional analytes (must be analyzed with same analyzer as mandatory analytes listed above): - Golimumab, concentration from serum (approximately 150 samples per year) - Golimumab anti-drug antibodies from serum (approximately maximum 50 per year). Specify, is this test measuring free anti-drug antibodies, total anti-drug antibodies, or are both assay types (free and total) available. - Infliximab anti-drug antibodies from serum (approximately 200 samples per year). Spe...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Request for Information: Equipment and Reagents for the Analysis of Biological Drug Assays - Finland Tender

The HUS-YHTYMÄ, a Government sector organization in Finland, has announced a new tender for Request for Information: Equipment and Reagents for the Analysis of Biological Drug Assays. This tender is published on FinlandTenders under FIT Ref No: 115299202 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-11.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.